Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FXJC0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,269
Award facts
- Contract value 100% obligated
- $24,268.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,268.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) with a completion date of May 30, 2025. This non-set-aside competitive award was issued on May 29, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfilled this order under its larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to military healthcare programs worldwide.
This delivery order represents a routine pharmaceutical procurement supporting federal healthcare operations. AmerisourceBergen Drug Corp's extensive portfolio of competitively awarded federal contracts demonstrates its established capability to meet DLA medical supply requirements across diverse therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. The firm fixed-price structure and non-set-aside designation reflect the open competitive procurement environment typical of DLA pharmaceutical acquisitions, positioning this vendor among multiple contractors supporting the Defense Health Agency and other government healthcare systems through flexible contract vehicles.
Quick answers
Who was awarded contract SPE2DB25FXJC0?
SPE2DB25FXJC0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 29, 2025.
How much is contract SPE2DB25FXJC0 worth?
The government has obligated $24,269 on SPE2DB25FXJC0.
Is contract SPE2DB25FXJC0 an order under another contract?
Yes. SPE2DB25FXJC0 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB25FXJC0 competed?
The extent of competition for SPE2DB25FXJC0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award